Literature DB >> 3872068

Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome.

H C Lane, H Masur, E P Gelmann, D L Longo, R G Steis, T Chused, G Whalen, L C Edgar, A S Fauci.   

Abstract

The present study was designed to determine whether there was a significant correlation between the clinical presentation of patients with AIDS or AIDS-related illnesses and the degree of their underlying immunologic abnormalities. In 17 patients who presented with opportunistic infections, the mean number of T4 lymphocytes was 34/mm3 and the mean proliferative response to phytohemagglutinin 26,000 cpm; in 12 patients who presented with Kaposi's sarcoma alone, the mean number of T4 cells was 231/mm3 and the mean proliferative response to phytohemagglutinin, 32,809 cpm; and in nine patients with the lymphadenopathy syndrome, the mean number of T4 cells was 703/mm3 and the mean proliferative response to phytohemagglutinin, 49,317 cpm. These findings suggest that those patients who present with opportunistic infections as their initial clinical manifestation of AIDS may represent a subgroup with a more severe immunologic derangement prior to clinical diagnosis. Thus, in those who have a predisposition to Kaposi's sarcoma, this disease will often develop, prior to the development of T cell dysfunction, to the degree of that in those who present with opportunistic infections. This finding is of importance in attempts to understand the pathogenesis of this syndrome and in the design of therapeutic trials.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Biology; Cancer; Developed Countries; Developing Countries; Diseases; Hiv Infections; Immunity; Immunological Effects; Infections; Neoplasms; North America; Northern America; Physiology; United States; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 3872068     DOI: 10.1016/0002-9343(85)90332-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  37 in total

1.  The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.

Authors:  Hiromi Imamichi; Richard A Lempicki; Joseph W Adelsberger; Rebecca B Hasley; Alice Rosenberg; Gregg Roby; Catherine A Rehm; Amy Nelson; Sonya Krishnan; Mark Pavlick; Christian J Woods; Michael W Baseler; H Clifford Lane
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

Review 2.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

3.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Authors:  J A Kovacs; M B Vasudevachari; M Easter; R T Davey; J Falloon; M A Polis; J A Metcalf; N Salzman; M Baseler; G E Smith
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy.

Authors:  O Prakash; G H Porter
Journal:  Ochsner J       Date:  1999-04

6.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Immunohistology of tuberculous adenitis in symptomatic HIV infection.

Authors:  J Y Shen; P F Barnes; T H Rea; P R Meyer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database.

Authors:  H Byakwaga; K Petoumenos; J Ananworanich; F Zhang; M A Boyd; T Sirisanthana; P C K Li; C Lee; C V Mean; V Saphonn; S F S Omar; S Pujari; P Phanuphak; P L Lim; N Kumarasamy; Y M A Chen; T P Merati; S Sungkanuparph; R Ditangco; S Oka; G Tau; J Zhou; M G Law; S Emery
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-02-19

9.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Authors:  C A Lee; A N Phillips; J Elford; G Janossy; P Griffiths; P Kernoff
Journal:  BMJ       Date:  1991-11-02

10.  The effects of immune status and race on health service use among people with HIV disease.

Authors:  J D Piette; V Mor; K Mayer; S Zierler; T Wachtel
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.